TECH
Bio-Techne Corp
A maker of the proteins, antibodies, and lab instruments that scientists use to study cells and diagnose disease, Bio-Techne sells brands like R&D Systems and ProteinSimple to researchers worldwide. It began in 1976 in Minneapolis as R&D Systems, making controls to verify blood-analysis machines, and rebranded as Bio-Techne in 2014 — a name blending "bio" with the Greek word "techne," meaning art or craft. Its first product, launched in 1977, was a platelet-rich-plasma control.
CUSIP: 09073M104HealthcareUS7 holders
Recent Activity
2026Q2
2 buys6 sells
-196.9K shares
-196.9K shares
+20.8K shares(+347.5%)
+20.8K shares(+347.5%)
-3.95M shares(-88.7%)
-3.95M shares(-88.7%)
-49.6K shares(-1.8%)
Mairs & PowerTRIM
-49.6K shares(-1.8%)
-5.8K shares(-0.4%)
-5.8K shares(-0.4%)
-3.20M shares(-67.6%)
Maverick CapitalTRIM
-3.20M shares(-67.6%)
+82.4K shares(+6.3%)
Sequoia FundADD
+82.4K shares(+6.3%)
-110.0K shares(-16.8%)
-110.0K shares(-16.8%)
2026Q1
4 buys4 sells
-30.5K shares(-13.4%)
-30.5K shares(-13.4%)
+6.0K shares
+6.0K shares
+2.37M shares(+113.3%)
+2.37M shares(+113.3%)
-17.3K shares(-0.6%)
Mairs & PowerTRIM
-17.3K shares(-0.6%)
-42.8K shares(-2.9%)
-42.8K shares(-2.9%)
+888.8K shares(+23.1%)
+888.8K shares(+23.1%)
+1.30M shares
Sequoia FundNEW
+1.30M shares
-149.8K shares(-18.6%)
-149.8K shares(-18.6%)
Loading more activity...